Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.2540
+0.0010 (0.40%)
At close: Jun 9, 2026, 4:00 PM EDT
0.2450
-0.0090 (-3.54%)
Pre-market: Jun 10, 2026, 7:28 AM EDT
Nations Trust Bank Market Cap
Ensysce Biosciences has a market cap or net worth of $2.36 million as of June 10, 2026. Its market cap has decreased by -54.19% in one year.
Market Cap
2.36M
Enterprise Value
1.86M
1-Year Change
-54.19%
Ranking
Category
Stock Price
0.25
Market Cap Chart
Since February 26, 2018, Ensysce Biosciences's market cap has decreased from $59.64B to $2.36M, a decrease of -100.00%. That is a compound annual growth rate of -70.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 2.35M | -29.76% |
| Dec 31, 2025 | 3.34M | -68.54% |
| Dec 31, 2024 | 10.62M | 218.52% |
| Dec 29, 2023 | 3.33M | -30.67% |
| Dec 30, 2022 | 4.81M | -95.78% |
| Dec 31, 2021 | 113.99M | -99.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Azitra | 3.42M |
| Adial Pharmaceuticals | 3.16M |
| GRI Bio | 2.89M |
| Oragenics | 2.68M |
| Calidi Biotherapeutics | 2.60M |
| Valion Bio | 2.39M |
| Bone Biologics | 2.24M |
| Biodexa Pharmaceuticals | 2.18M |